ArticleJournal of bone metabolism2018
New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia.
Article in Journal of bone metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 34 citations in OpenAlex.
- Trial
- Effectiveness of a Novel Food Composed of Leucine, Omega-3 Fatty Acids and ProbioticNutrients · 2022Trial
- Article
- Article
- Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis.Lipids in health and disease · 2025Article
- Association between Clinical Characteristics and Sarcopenia or Sarcopenic Obesity in Crohn's Disease.Internal medicine (Tokyo, Japan) · 2025Article
- Article
- The Role of BIA Analysis in Osteoporosis Risk Development: Hierarchical Clustering Approach.Diagnostics (Basel, Switzerland) · 2023Article
- The association of dietary acid load (DAL) with estimated skeletal muscle mass and bone mineral content: a cross-sectional study.BMC nutrition · 2023Article
- 3D Body shape for regional and appendicular body composition estimation.Proceedings of SPIE--the International Society for Optical Engineering · 2023Article
- Association of the Bioimpedance Phase Angle and Quality of Life in Postmenopausal Osteoporosis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2023Article
- Characterization of serum protein expression profiles in the early sarcopenia older adults with low grip strength: a cross-sectional study.BMC musculoskeletal disorders · 2022Article
- Sarcopenia in people living with HIV in Hong Kong: which definition correlates with health outcomes?Journal of the International AIDS Society · 2022Article
- Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults.European journal of endocrinology · 2022Article
- The relationship of dietary total antioxidant capacity with sarcopenia and cardiometabolic biomarkers in type 2 diabetes patients.Physiological reports · 2022Article
- DXA-Derived Indices in the Characterisation of Sarcopenia.Nutrients · 2021Observational
- Curcumin-Loaded Hydrophobic Surface-Modified Hydroxyapatite as an Antioxidant for Sarcopenia Prevention.Antioxidants (Basel, Switzerland) · 2021Article
- To Synthesize Hydroxyapatite by Modified Low Temperature Method Loaded withAntioxidants (Basel, Switzerland) · 2021Article
- Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.The Journal of clinical endocrinology and metabolism · 2020Article
- Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial.Frontiers in endocrinology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe sought to develop a novel index based on the skeletal muscle mass that reflects the change of quality of life (QOL), and is the most appropriate index for the body composition of the elderly in Korea. Whether lower extremity skeletal muscle mass index (LESMI) is an appropriate novel new index to diagnose patients with sarcopenia was also evaluated. A cut-off value for each index was reported to facilitate the diagnosis of patients with sarcopenia in a Korean population.
methodsWe used the 5th Korean National Health and Nutrition Examination Survey data from 2010. We analyzed 409 elderly patients, including 231 men and 178 women, aged ≥65 years. Patients were diagnosed by calculating their skeletal muscle index based on the skeletal muscle mass measured using dual energy X-ray absorptiometry. Obesity and osteoporosis were used to screen data and EuroQOL-5 dimension as a health questionnaire.
resultsThe prevalence of sarcopenia in each index was obtained based on its cut-off value for diagnosing sarcopenia. There was a significant difference between the obesity rate of elderly patients diagnosed with sarcopenia and those who were not based on each index. There was no significant difference in the prevalence of osteoporosis between the groups. Sarcopenia diagnosis based on the LESMI was significantly correlated with QOL.
conclusionsLESMI, a novel index based on skeletal muscle mass, reflects changes in QOL and is appropriate for the body composition of elderly people in Korea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.